K-numberK242996
Device nameEndyMed PRO MAX
ApplicantEndymed Medical, Ltd.
Product codeGEI
Device classClass II
Decision dateJun 10, 2025
DecisionSubstantially Equivalent
Regulation
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The EndyMed PRO MAX is a radiofrequency device system consisting of a console and seven interchangeable handpieces for dermatologic procedures. Different handpieces treat muscle pain and spasm, improve blood circulation, reduce wrinkle appearance (at ≤65W), perform skin ablation and resurfacing, or provide electrocoagulation and hemostasis, depending on the handpiece used.

Technological characteristics

The system operates at bipolar radiofrequency (1 MHz) with maximum output power up to 100W across handpieces, compared to predicates ranging 65–85W. It features an optional thermal camera for temperature monitoring and water cooling, versus fan cooling in the predicate. New handpieces (iFine Max, Mini Shaper Max) are physically smaller with lower power density but maintain therapeutic tissue heating at 39–45°C. Patient-contacting materials remain biocompatible with options for stainless steel or copper-plated electrodes.

Test standards cited

IEC 60601-1:2005+A1:2012; IEC 60601-1-2:2014; IEC 60601-2-2:2017; IEC 62304:2006+A1:2015; EN ISO 14971:2012; ISO 11135 (2014); ISO 10993-1:2018; ISO 11607-1:2019-02. Bench testing verified RF energy accuracy; tissue heating testing on human subjects confirmed therapeutic temperature maintenance (39–45°C for ≥10 minutes).

Substantial equivalence argument

The EndyMed PRO MAX combines previously cleared handpieces (Imagine TC, Contour, Intensif, FSR) into one system with minor modifications (increased wattage, optional thermal camera) and two new smaller handpieces. All operate on identical bipolar RF principles at the same frequency and mode. Tissue heating testing demonstrates the new and modified handpieces achieve and maintain the same therapeutic temperature range as predicates, establishing functional equivalence for pain relief indications. Power density differences on newer handpieces do not introduce additional safety risks and are offset by larger electrode surface areas or lower absolute power to maintain equivalent performance.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →